PSEN1 Gene Alzheimer Disease Type 3 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for PSEN1 Gene Alzheimer Disease Type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PSEN1 Gene Alzheimer Disease Type 3.
Test Details
The PSEN1 gene is associated with Alzheimer’s disease type 3, which is an early-onset form of the disease that usually begins before the age of 65. This gene provides instructions for making a protein called presenilin 1, which is involved in the processing of amyloid precursor protein (APP) in the brain.
Mutations in the PSEN1 gene can lead to the production of abnormal forms of APP, which can accumulate in the brain and form plaques that are characteristic of Alzheimer’s disease.
NGS (next-generation sequencing) genetic testing can be used to detect mutations in the PSEN1 gene. This type of testing involves sequencing the entire gene to identify any changes or variations in the DNA sequence that may be associated with Alzheimer’s disease.
NGS testing can be performed using a blood sample or other tissue sample, and can provide a rapid and accurate diagnosis of genetic disorders like Alzheimer’s disease.
Test Name | PSEN1 Gene Alzheimer disease type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PSEN1 Gene Alzheimer disease type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PSEN1 Gene Alzheimer disease type 3 |
Test Details |
The PSEN1 gene is associated with Alzheimer’s disease type 3, which is an early-onset form of the disease that usually begins before the age of 65. This gene provides instructions for making a protein called presenilin 1, which is involved in the processing of amyloid precursor protein (APP) in the brain. Mutations in the PSEN1 gene can lead to the production of abnormal forms of APP, which can accumulate in the brain and form plaques that are characteristic of Alzheimer’s disease. NGS (next-generation sequencing) genetic testing can be used to detect mutations in the PSEN1 gene. This type of testing involves sequencing the entire gene to identify any changes or variations in the DNA sequence that may be associated with Alzheimer’s disease. NGS testing can be performed using a blood sample or other tissue sample, and can provide a rapid and accurate diagnosis of genetic disorders like Alzheimer’s disease. |